Multisystem Inflammatory Syndrome in a Young Adult (MIC-A) Following SARS-CoV-2 Infection
Abstract
:1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Payne, A.B.; Gilani, Z.; Godfred-Cato, S.; Belay, E.D.; Feldstein, L.R.; Patel, M.M.; Randolph, A.G.; Newhams, M.; Thomas, D.; Magleby, R.; et al. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected with SARS-CoV-2. JAMA Netw. Open 2021, 4, e2116420. [Google Scholar] [CrossRef]
- Henderson, L.A.; Canna, S.W.; Friedman, K.G.; Gorelik, M.; Lapidus, S.K.; Bassiri, H.; Behrens, E.M.; Kernan, K.F.; Schulert, G.S.; Seo, P.; et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis Rheumatol. 2022, 74, e1–e20. [Google Scholar] [CrossRef]
- Patel, P.; DeCuir, J.; Abrams, J.; Campbell, A.P.; Godfred-Cato, S.; Belay, E.D. Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults: A Systematic Review. JAMA Netw. Open 2021, 4, e2126456. [Google Scholar] [CrossRef]
- Feldstein, L.R.; Rose, E.B.; Horwitz, S.M.; Collins, J.P.; Newhams, M.M.; Son, M.B.F.; Newburger, J.W.; Kleinman, L.C.; Heidemann, S.M.; Martin, A.A.; et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N. Engl. J. Med. 2020, 383, 334–346. [Google Scholar] [CrossRef]
- Feldstein, L.R.; Tenforde, M.W.; Friedman, K.G.; Newhams, M.; Rose, E.B.; Dapul, H.; Soma, V.L.; Maddux, A.B.; Mourani, P.M.; Bowens, C.; et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA 2021, 325, 1074–1087. [Google Scholar] [CrossRef]
- Swann, O.V.; Holden, K.A.; Turtle, L.; Pollock, L.; Fairfield, C.J.; Drake, T.M.; Seth, S.; Egan, C.; Hardwick, H.E.; Halpin, S.; et al. Clinical characteristics of children and young people admitted to hospital with COVID-19 in United Kingdom: Prospective multicentre observational cohort study. BMJ 2020, 370, m3249. [Google Scholar] [CrossRef]
- Soriano, J.B.; Murthy, S.; Marshall, J.C.; Relan, P.; Diaz, J.V.; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022, 22, e102–e107. [Google Scholar] [CrossRef]
- Moreno-Perez, O.; Merino, E.; Leon-Ramirez, J.-M.; Andres, M.; Ramos, J.M.; Arenas-Jimenez, J.; Asensio, S.; Sanchez, R.; Ruiz-Torregrosa, P.; Galan, I.; et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J. Infect. 2021, 82, 378–383. [Google Scholar] [CrossRef]
- McCrindle, B.W.; Rowley, A.H.; Newburger, J.W.; Burns, J.C.; Bolger, A.F.; Gewitz, M.; Baker, A.L.; Jackson, M.A.; Takahashi, M.; Shah, P.B.; et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation 2017, 135, e927–e999. [Google Scholar] [CrossRef]
- Davi, S.; Minoia, F.; Pistorio, A.; Horne, A.; Consolaro, A.; Rosina, S.; Bovis, F.; Cimaz, R.; Gamir, M.L.; Ilowite, N.T.; et al. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2014, 66, 2871–2880. [Google Scholar] [CrossRef]
- Morris, S.B.; Schwartz, N.G.; Patel, P.; Abbo, L.; Beauchamps, L.; Balan, S.; Lee, E.H.; Paneth-Pollak, R.; Geevarughese, A.; Lash, M.K.; et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection—United Kingdom and United States, March-August 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 1450–1456. [Google Scholar] [CrossRef] [PubMed]
- Bulut, H.; Herbers, A.H.E.; Hageman, I.M.G.; Netten, P.M.; de Jonge, H.J.M.; Joustra, R.; van de Veerdonk, F.L.; de Jager, C.P. SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report. SN Compr. Clin. Med. 2021, 3, 1773–1779. [Google Scholar] [CrossRef] [PubMed]
- Hekimian, G.; Kerneis, M.; Zeitouni, M.; Cohen-Aubart, F.; Chommeloux, J.; Brechot, N.; Mathian, A.; Lebreton, G.; Schmidt, M.; Hié, M.; et al. Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units. Chest 2021, 159, 657–662. [Google Scholar] [CrossRef] [PubMed]
- Sokolovsky, S.; Soni, P.; Hoffman, T.; Kahn, P.; Scheers-Masters, J. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult. Am. J. Emerg. Med. 2021, 39, e1–e253. [Google Scholar] [CrossRef] [PubMed]
- Most, Z.M.; Hendren, N.; Drazner, M.H.; Perl, T.M. Striking Similarities of Multisystem Inflammatory Syndrome in Children and a Myocarditis-Like Syndrome in Adults: Overlapping Manifestations of COVID-19. Circulation 2021, 143, 4–6. [Google Scholar] [CrossRef]
- Gupta, A.; Madhavan, M.V.; Sehgal, K.; Nair, N.; Mahajan, S.; Sehrawat, T.S.; Bikdeli, B.; Ahluwalia, N.; Ausiello, J.C.; Wan, E.Y.; et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020, 26, 1017–1032. [Google Scholar] [CrossRef]
- Gruber, C.N.; Patel, R.S.; Trachtman, R.; Lepow, L.; Amanat, F.; Krammer, F.; Wilson, K.M.; Onel, K.; Geanon, D.; Tuballes, K.; et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). Cell 2020, 183, 982–995.e14. [Google Scholar] [CrossRef]
- Vella, L.A.; Giles, J.R.; Baxter, A.E.; Oldridge, D.A.; Diorio, C.; Kuri-Cervantes, L.; Alanio, C.; Pampena, M.B.; Wu, J.E.; Chen, Z.; et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci. Immunol. 2021, 6, eabf7570. [Google Scholar] [CrossRef]
- Menon, N.M.; Srivaths, L.V. Thromboembolism in children with multisystem inflammatory syndrome: A literature review. Pediatr. Res. 2022. [Google Scholar] [CrossRef]
- Llitjos, J.-F.; Leclerc, M.; Chochois, C.; Monsallier, J.-M.; Ramakers, M.; Auvray, M.; Merouani, K. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J. Thromb. Haemost. 2020, 18, 1743–1746. [Google Scholar] [CrossRef]
- Dufort, E.M.; Koumans, E.H.; Chow, E.J.; Rosenthal, E.M.; Muse, A.; Rowlands, J.; Barranco, M.A.; Maxted, A.M.; Rosenberg, E.S.; Easton, D.; et al. Multisystem Inflammatory Syndrome in Children in New York State. N. Engl. J. Med. 2020, 383, 347–358. [Google Scholar] [CrossRef] [PubMed]
- Cavalli, G.; Larcher, A.; Tomelleri, A.; Campochiaro, C.; Della-Torre, E.; De Luca, G.; Farina, N.; Boffini, N.; Ruggeri, A.; Poli, A.; et al. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: A cohort study. Lancet Rheumatol. 2021, 3, e253–e261. [Google Scholar] [CrossRef]
- Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Bethesda (MD)2021. Available online: https://www.ncbi.nlm.nih.gov/books/NBK570371/ (accessed on 30 September 2022).
- Levy, M.; Recher, M.; Hubert, H.; Javouhey, E.; Flechelles, O.; Leteurtre, S.; Angoulvant, F. Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France. JAMA 2022, 327, 281–283. [Google Scholar] [CrossRef] [PubMed]
- Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States. Available online: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#covid19-vaccination-misc-misa (accessed on 13 September 2022).
Characteristics | Values (Reference Values) |
---|---|
I. MIC-A clinical criteria * | |
Documented persistent fever (≥38.0 °C) and at least 3 of the following clinical criteria **: | Yes |
A. Primary clinical criteria | |
1. Severe cardiac illness | Yes |
2. Rash and non-purulent conjunctivitis | Yes |
B. Secondary clinical criteria | |
1. New-onset neurologic signs and symptoms | No |
2. Shock or hypotension not attributable to medical therapy | Yes |
3. Abdominal pain, vomiting, or diarrhea | Yes |
4. Thrombocytopenia | Yes |
II. MIC-A laboratory evidence | |
The presence of laboratory evidence of inflammation and SARS-CoV-2 infection *** | Yes |
Chest radiography/computer tomography | Bilateral interstitial densities and pleural effusions. |
Ultrasound findings on heart | Tachycardia 120 beats/min, mild systolic dysfunction, a pericardial effusion. |
Laboratory findings | |
Nasopharyngeal SARS-CoV-2 PCR | Negative |
Serum SARS-CoV-2 IgG levels (BAU/mL) | 75.4 (<=21) |
Leukocyte count (×109 L) | 19.4 (3.6–10.2) |
Lymphocyte count (×109 L) | 0.1 (1.1–3.2) |
Neutrophil count (×109 L) | 19 (1.7–7.6) |
Thrombocyte count (×109 L) | 140 (152–348) |
C reactive protein (mg/L) | 196 (0–5) |
Procalcitonin (µg/L) | 2.76 (0–0.1) |
D-dimers (mg/L) | 7.6 (0–0.5) |
Ferritin (µg/L) | 774 (25–380) |
Troponin I (ng/L) | 0.2 (0–0.04) |
B-type natriuretic peptide (ng/L) | 248 (0–26.5) |
LDH (U/L) | 326 (100–250) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bajoriunaite, A.; Zaveckiene, J.; Usaite, A.; Dobiliene, O.; Tamosuitis, T. Multisystem Inflammatory Syndrome in a Young Adult (MIC-A) Following SARS-CoV-2 Infection. Medicina 2022, 58, 1515. https://doi.org/10.3390/medicina58111515
Bajoriunaite A, Zaveckiene J, Usaite A, Dobiliene O, Tamosuitis T. Multisystem Inflammatory Syndrome in a Young Adult (MIC-A) Following SARS-CoV-2 Infection. Medicina. 2022; 58(11):1515. https://doi.org/10.3390/medicina58111515
Chicago/Turabian StyleBajoriunaite, Ausrine, Jurgita Zaveckiene, Akvile Usaite, Olivija Dobiliene, and Tomas Tamosuitis. 2022. "Multisystem Inflammatory Syndrome in a Young Adult (MIC-A) Following SARS-CoV-2 Infection" Medicina 58, no. 11: 1515. https://doi.org/10.3390/medicina58111515